MYC and prostate cancer: Glutamate can subsequently be converted into [4-13C]proline via Δ1-pyrroline-5-carboxylate, a process that has been shown to be up-regulated by oncogenic transcription factor c-MYC in prostate cancer cell line PC3 (78).